SciBase announces a Management team changeJune 30, 2020Anna Danström, SciBase's head of production and supply chain, has chosen to leave her position and accept a role at another company. Linn Olsen will replace Anna as production and supply chain manager. Linn has ...
SciBase installs Nevisense Systems at Advanced Dermatology and Cosmetic Surgery Group in FloridaJune 23, 2020
The nation's premier dermatology group begins rollout of Nevisense technology to examine patients with irregular moles suspicious of melanoma
Annual general meeting has been held in SciBase Holding AB (publ)June 17, 2020
Today, the annual general meeting of 2020 was held in SciBase Holding AB (publ) (the "Company" or "SciBase"). Below follows a summary of the resolutions passed at the annual general meeting (all in accordance with the proposals presented in the notice to attend the meeting kept available at the Company's website www.scibase.com).
SciBase submits reimbursement application and targets 2021 for first reimbursement coverage in the USJune 16, 2020
Stockholm, June 15th, 2020 - SciBase, a global healthcare company with a platform technology enabling innovative products for skin disorders such as skin cancer and atopic dermatitis, today announces that the company has submitted a reimbursement code application for its melanoma application to the Centers for Medicare & Medicaid Services (CMS) in the US.
DermaLive webinarJune 5, 2020Listen to the DermaLive webinar (in German), presenting “INNOVATIVE DIAGNOSTIC TOOLS IN DERMATOLOGY” (and receive CME credits). On line on June 10th at 6 PM (CET), or afterwards as a video-on-demand. Presenters are Prof Julia Welzel, Dr Martina Ulrich, Prof Uwe Reinhold and Prof Cezmi Akdis, and morderator is Prof Thomas Dirschka. Access through Streamed-up.com
SciBase’s rights issue heavily oversubscribedMay 28, 2020
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
- Load more news...